Abstract: A system and method is disclosed for requesting an updated location, including a point of interest, from a user for display on an interactive map. On receiving from an interested user a request for a point of interest associated with a subscribed user's current location, a request is transmitted to the subscribed user to check-in to the point of interest. In response to the request, the subscribed user selects a selected point of interest from a selection list. A representation of the subscribed user and the selected point of interest is then provided for display on an interactive map associated with the interested user.

Abstract: The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.

Abstract: The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.

Abstract: In one embodiment, a wireless access point is disclosed comprising a housing that defines a compartment and a plurality of apertures configured to receive a plurality of fasteners; a gasket located along a perimeter of the compartment; an access cover for the compartment that defines a plurality of corresponding apertures (that align substantially with the plurality of apertures of the housing); and a hinge coupled to the housing and to the access cover. The hinge includes a first arm affixed to an interior portion of the compartment and extended substantially along a first axis; a second arm connected to the first arm at a first pivot point; a third arm connected to the second arm at a second pivot point; and a fourth arm affixed to an interior portion of the access cover and connected to the third arm at a third pivot point.

Abstract: Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Abstract: Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Abstract: Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Abstract: Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Abstract: A volatile content analysis instrument is disclosed that includes a cavity and a microwave source positioned to produce and direct microwaves into the cavity at frequencies other than infrared frequencies. A balance is included with at least the balance pan (or platform) in the cavity. An infrared source is positioned to produce and direct infrared radiation into the cavity at frequencies other than the microwave frequencies produced by the microwave source. A lens is positioned between the infrared source and the balance pan for more efficiently directing infrared radiation to a sample on the balance pan. The lens has dimensions that preclude microwaves of the frequencies produced by the source and directed into the cavity from leaving the cavity.

Abstract: Graph-based detection systems and techniques are provided to identify potential malicious lateral movement paths. System and security events may be used to generate a network connection graph and detect remote file executions and/or other detections, for use in tracking malicious lateral movement across a computer network, such as a compromised computer network. Lateral movement determination across a computer network may be divided into two subproblems: forensic analysis and general detection. With forensic analysis, given a malicious node, possible lateral movement leading into or out of the node is identified. General detection identifies previously unknown malicious lateral movement on a network using a remote file execution detector, and/or other detectors, and a rare path anomaly detection algorithm.

Abstract: A volatile content analysis instrument is disclosed that includes a cavity and a microwave source positioned to produce and direct microwaves into the cavity at frequencies other than infrared frequencies. A balance is included with at least the balance pan (or platform) in the cavity. An infrared source is positioned to produce and direct infrared radiation into the cavity at frequencies other than the microwave frequencies produced by the microwave source. A lens is positioned between the infrared source and the balance pan for more efficiently directing infrared radiation to a sample on the balance pan. The lens has dimensions that preclude microwaves of the frequencies produced by the source and directed into the cavity from leaving the cavity.

Abstract: The present invention relates to therapeutic methods of using stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, and kits comprising the formulations for treating subjects suffering from atypical hemolytic uremic syndrome (aHUS).

Abstract: Graph-based detection systems and techniques are provided to identify potential malicious lateral movement paths. System and security events may be used to generate a network connection graph and detect remote file executions and/or other detections, for use in tracking malicious lateral movement across a computer network, such as a compromised computer network. Lateral movement determination across a computer network may be divided into two subproblems: forensic analysis and general detection. With forensic analysis, given a malicious node, possible lateral movement leading into or out of the node is identified. General detection identifies previously unknown malicious lateral movement on a network using a remote file execution detector, and/or other detectors, and a rare path anomaly detection algorithm.

Abstract: Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Abstract: Disclosed is are formulations comprising a multivesicular liposome and MTX, the administration of which results in a Cmax of MTX between 5% and 50% of the Cmax of an immediate release dosage form of MTX, the duration of which lasts from about 1 to about 30 days. Also disclosed are methods of treating autoimmune diseases and cancer by administering these formulations of MTX.

Abstract: The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.

Abstract: Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Abstract: Most machines in an organization's computer network connect to the Internet and create web traffic logs which allow analysis of HTTP traffic in a simple, centralized way. The web traffic logs may contain error reports and error reports contain significant information that can be used to detect network security. By reviewing the error reports, significant information about a network and its security can be found as common sources of network security weakness may be watched for in the error reports.

Abstract: A volatile content analysis instrument is disclosed that includes a cavity and a microwave source positioned to produce and direct microwaves into the cavity at frequencies other than infrared frequencies. A balance is included with at least the balance pan (or platform) in the cavity. An infrared source is positioned to produce and direct infrared radiation into the cavity at frequencies other than the microwave frequencies produced by the microwave source. A lens is positioned between the infrared source and the balance pan for more efficiently directing infrared radiation to a sample on the balance pan. The lens has dimensions that preclude microwaves of the frequencies produced by the source and directed into the cavity from leaving the cavity.

Abstract: Concepts and technologies are described herein for evaluating shellcode findings. In accordance with the concepts and technologies disclosed herein, shellcode findings can be evaluated to determine if the shellcode findings are legitimate, or if the shellcode findings are false positive shellcode findings. Legitimate shellcode findings can be determined based not simply upon patterns associated with the suspected shellcode itself, but also based upon a pattern of bit-level entropy in the memory around the suspected shellcode. Mathematical models of the memory can be generated and analyzed to determine if the shellcode finding is legitimate.